ArticleDiabetology & metabolic syndrome2026
Obstructive sleep apnea a synergistic health risk in type 2 diabetes mellitus: a cross-sectional analytical study using STOP-BANG questionnaire in a tertiary care teaching hospital of Eastern Odisha.
Article in Diabetology & metabolic syndrome, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundType 2 diabetes mellitus (T2DM) is frequently associated with vascular complications and sleep-disordered breathing, particularly obstructive sleep apnea (OSA), which adversely affects glycemic control. This study aimed to evaluate the risk of OSA among patients with T2DM and to promote awareness among physicians for early detection and improved management.
methodsA hospital-based, cross-sectional analytical study was conducted among 448 T2DM patients attending the Endocrinology Department of IMS and SUM Hospital, a tertiary care centre in Eastern Odisha, from March to September 2022. OSA risk was assessed using the validated STOP-BANG questionnaire. Categorical variables were analysed using frequency distribution and Chi-square tests. Odds ratios (ORs) with 95% confidence intervals (CI) were calculated, and multivariate logistic regression identified predictors of high OSA risk. Data analysis was performed using SPSS version 24.0.
resultsOf the 448 participants, 286 (63.8%) were aged > 50 years, 249 (55.6%) were male, and 199 (44.4%) were female. The median STOP-BANG score was 3 (range 0–8), and 61.6% were categorized as high risk for OSA. Significant associations were observed between high OSA risk and obesity, hypertension, large neck and hip circumference, poor glycaemic control, and longer diabetes duration. Multivariate analysis confirmed these as independent predictors of OSA risk.
conclusionOver half of T2DM patients were at high risk for OSA. Routine OSA screening using simple tools such as STOP-BANG in diabetes clinics is recommended for early screening, better glycaemic control, and reduced cardiovascular morbidity. Hence, using the STOP-BANG questionnaire helps in screening for the risk of OSA in diabetes mellitus, though the gold standard for OSA diagnosis is polysomnography.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.